Role of β5-integrin in epithelial-mesenchymal transition in response to TGFβ

Cell Cycle

Volumn 9, Issue 8, 2010, Pages 1647-1659

  Bianchi, Anna ^a   Gervasi, Megan E ^a   Bakin, Andrei V ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Actin fibers; Epithelial mesenchymal transition; Focal adhesion; Integrin; Invasion; TGF

Indexed keywords

ALPHAVBETA5 INTEGRIN; ARGINYLGLYCYLASPARTIC ACID; BETA1 INTEGRIN; FOCAL ADHESION KINASE; SMAD3 PROTEIN; SMAD4 PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN;

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CARCINOGENESIS; CARCINOMA CELL; CELL ADHESION; CELL INVASION; CELL STRUCTURE; CONTROLLED STUDY; ENZYME INHIBITION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MESENCHYME CELL; MOUSE; NONHUMAN; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 77953550880     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.8.11517     Document Type: Article

References (79)

1. Thiery J. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003; 15:740-6.
2. Zavadil J, Bottinger EP. TGF[beta] and epithelial-tomesenchymal transitions. Oncogene 2006; 24:5764-74.
3. Piek E, Moustakas A, Kurisaki A, Heldin CH, ten Dijke P. TGF(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J Cell Sci 1999; 112:4557-68. (Pubitemid 30034805)
4. Bakin AV, Safina A, Rinehart C, Daroqui C, Darbary H, Helfman DM. A Critical Role of Tropomyosins in TGF{beta} Regulation of the Actin Cytoskeleton and Cell Motility in Epithelial Cells. Mol Biol Cell 2004; 15:4682-94. (Pubitemid 39299114)
5. Miettinen PJ, Ebner R, Lopez AR, Derynck R. TGFbeta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 1994; 127:2021-36.
6. Oft M, Peli J, Rudaz C, Schwarz H, Beug H, Reichmann E. TGFbeta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev 1996; 10:2462-77. (Pubitemid 26341881)
7. Brown K, Aakre M, Gorska A, Price J, Eltom S, Pietenpol J, Moses H. Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro. Breast Cancer Res 2004; 6:215-31.
8. Tian Y-C, Fraser D, Attisano L, Phillips AO. TGF{beta}1-mediated alterations of renal proximal tubular epithelial cell phenotype. Am J Physiol Renal Physiol 2003; 285:130-42. (Pubitemid 36818470)
9. Tian YC, Phillips AO. TGFbeta1-mediated inhibition of HK-2 cell migration. J Am Soc Nephrol 2003; 14:631-40.
10. Savagner P, Yamada KM, Thiery JP. The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelialmesenchymal transition. J Cell Biol 1997; 137:1403-19. (Pubitemid 27265951)
11. Zheng Q, Safina A, Bakin AV. Role of high-molecular weight tropomyosins in TGFbeta-mediated control of cell motility. International Journal of Cancer 2008; 122:78-90. (Pubitemid 350209981)
12. Safina A, Varga AE, Bianchi A, Zheng Q, Kunnev D, Liang P, Bakin AV. RAS alters epithelial-mesenchymal transition in response to TGFbeta by reducing actin fibers and cell-matrix adhesion. Cell Cycle 2009; 8:284-98.
13. Stover DG, Bierie B, Moses HL. A delicate balance: TGFbeta and the tumor microenvironment. J Cell Biochem 2007; 101:851-61. (Pubitemid 47040867)
14. Lee JM, Dedhar S, Kalluri R, Thompson EW. The epithelial-mesenchymal transition: new insights in signaling, development and disease. J Cell Biol 2006; 172:973-81.
15. Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005; 17:548-58. (Pubitemid 41267170)
16. Maehara Y, Kakeji Y, Kabashima A, Emi Y, Watanabe A, Akazawa K, et al. Role of transforming growth factor-beta1 in invasion and metastasis in gastric carcinoma. J Clin Oncol 1999; 17:607-14. (Pubitemid 29075249)
17. Valcourt U, Kowanetz M, Niimi H, Heldin C-H, Moustakas A. TGF{beta} and the Smad Signaling Pathway Support Transcriptomic Reprogramming during Epithelial-Mesenchymal Cell Transition. Mol Biol Cell 2005; 16:1987-2002.
18. Levy L, Hill CS. Smad4 Dependency Defines Two Classes of Transforming Growth Factor{beta} (TGF{beta}) Target Genes and Distinguishes TGF{beta}-Induced Epithelial-Mesenchymal Transition from Its Antiproliferative and Migratory Responses. Mol Cell Biol 2005; 25:8108-25.
19. Bhowmick NA, Ghiassi M, Bakin AV, Aakre M, Lundquist CA, Engel M, et al. TGFb mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 2001; 12:27-36.
20. Bakin AV, Rinehart C, Tomlinson AK, Arteaga CL. p38 mitogen-activated protein kinase is required for TGF{beta}-mediated fibroblastic transdifferentiation and cell migration. J Cell Sci 2002; 115:3193-206.
21. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL. Phosphatidylinositol 3-kinase function is required for TGFbeta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 2000; 275:36803-10.
22. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, Garcia De Herreros A. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000; 2:84-9.
23. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000; 2:76-83.
24. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 2001; 7:1267-78.
25. Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 1999; 147:631-44.
26. Islam S, Carey TE, Wolf GT, Wheelock MJ, Johnson KR. Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. J Cell Biol 1996; 135:1643-54. (Pubitemid 26427658)
27. Maeda M, Johnson KR, Wheelock MJ. Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition. J Cell Sci 2005; 118:873-87. (Pubitemid 40484880)
28. Boyer B, Dufour S, Thiery JP. E-cadherin expression during the acidic FGF-induced dispersion of a rat bladder carcinoma cell line. Exp Cell Res 1992; 201:347-57.
29. Bolos V, Peinado H, Perez-Moreno MA, Fraga MF, Esteller M, Cano A. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci 2003; 116:499-511. (Pubitemid 36231290)
30. Hajra KM, Chen DY, Fearon ER. The SLUG zincfinger protein represses E-cadherin in breast cancer. Cancer Res 2002; 62:1613-8.
31. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117:927-39. (Pubitemid 38798858)
32. Guaita S, Puig I, Franci C, Garrido M, Dominguez D, Batlle E, et al. Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J Biol Chem 2002; 277:39209-16. (Pubitemid 35190890)
33. Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, Schreiber M, et al. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 2005; 24:2375-85. (Pubitemid 40546696)
34. Siegel PM, Massague J. Cytostatic and apoptotic actions of TGFbeta in homeostasis and cancer. Nat Rev Cancer 2003; 3:807-21.
35. Pawlak G, Helfman DM. Cytoskeletal changes in cell transformation and tumorigenesis. Curr Opin Genet Dev 2001; 11:41-7. (Pubitemid 32119276)
36. Zaidel-Bar R, Cohen M, Addadi L, Geiger B. Hierarchical assembly of cell-matrix adhesion complexes. Biochem Soc Trans 2004; 32:416-20. (Pubitemid 38813527)
37. Giancotti FG, Ruoslahti E. Integrin signaling. Science 1999; 285:1028-32.
38. Legate KR, Wickstrom SA, Fassler R. Genetic and cell biological analysis of integrin outside-in signaling. Genes Dev 2009; 23:397-418.
39. MAPK and Epithelial Plasticity. J Biol Chem 2001; 276:46707-13.
40. Li Y, Yang J, Dai C, Wu C, Liu Y. Role for integrinlinked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest 2003; 112:503-16. (Pubitemid 38056335)
41. Somasiri A, Howarth A, Goswami D, Dedhar S, Roskelley CD. Overexpression of the integrin-linked kinase mesenchymally transforms mammary epithelial cells. J Cell Sci 2001; 114:1125-36. (Pubitemid 32288526)
42. Galliher AJ, Schiemann WP. Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells. Breast Cancer Res 2006; 8:42.
43. Reynolds LE, Conti FJ, Lucas M, Grose R, Robinson S, Stone M, et al. Accelerated re-epithelialization in beta3- integrin-deficient-mice is associated with enhanced TGFbeta1 signaling. Nat Med 2005; 11:167-74. (Pubitemid 40321352)
44. Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFbeta activation. J Cell Sci 2003; 116:217-24.
45. Wipff P-J, Hinz B. Integrins and the activation of latent transforming growth factor [beta]1 - An intimate relationship. European Journal of Cell Biology 2008; 87:601-15.
46. Aluwihare P, Mu Z, Zhao Z, Yu D, Weinreb PH, Horan GS, et al. Mice that lack activity of {alpha} v{beta}6- and {alpha}v{beta}8-integrins reproduce the abnormalities of Tgfb1- and Tgfb3-null mice 1242/ jcs.035246. J Cell Sci 2009; 122:227-32.
47. McCarty JH, Barry M, Crowley D, Bronson RT, Lacy-Hulbert A, Hynes RO. Genetic ablation of alphav integrins in epithelial cells of the eyelid skin and conjunctiva leads to squamous cell carcinoma. Am J Pathol 2008; 172:1740-7. (Pubitemid 351793364)
48. Mitra SK, Hanson DA, Schlaepfer DD. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 2005; 6:56-68.
49. Turner CE. Paxillin and focal adhesion signalling. Nat Cell Biol 2000; 2:231-6.
50. Gottardi CJ, Arpin M, Fanning AS, Louvard D. The junction-associated protein, zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cell-cell contacts. Proc Natl Acad Sci USA 1996; 93:10779-84.
51. Fogg VC, Liu CJ, Margolis B. Multiple regions of Crumbs3 are required for tight junction formation in MCF10A cells. J Cell Sci 2005; 118:2859-69.
52. Pellegrin S, Mellor H. Actin stress fibres. J Cell Sci 2007; 120:3491-9.
53. Kim Y, Kugler MC, Wei Y, Kim KK, Li X, Brumwell AN, Chapman HA. Integrin alpha3beta1-dependent beta-catenin phosphorylation links epithelial Smad signaling to cell contacts. J Cell Biol 2009; 184:309-22.
54. Siegel PM, Shu W, Massague J. Mad upregulation and Id2 repression accompany transforming growth factor (TGF)beta-mediated epithelial cell growth suppression. J Biol Chem 2003; 278:35444-50.
55. Bakin AV, Stourman NV, Sekhar KR, Rinehart C, Yan X, Meredith MJ, et al. Smad3-ATF3 signaling mediates TGFbeta suppression of genes encoding Phase II detoxifying proteins. Free Radic Biol Med 2005; 38:375-87.
56. Ignotz R, Heino J, Massague J. Regulation of cell adhesion receptors by transforming growth factor-beta. Regulation of vitronectin receptor and LFA-1. J Biol Chem 1989; 264:389-92.
57. Ignotz RA, Massagué J. Cell adhesion protein receptors as targets for transforming growth factor-[beta] action. Cell 1987; 51:189-97.
58. Smith JW, Vestal DJ, Irwin SV, Burke TA, Cheresh DA. Purification and functional characterization of integrin alphavbeta5. An adhesion receptor for vitronectin. J Biol Chem 1990; 265:11008-13.
59. Bodary SC, McLean JW. The integrin beta1 subunit associates with the vitronectin receptor alphav subunit to form a novel vitronectin receptor in a human embryonic kidney cell line. J Biol Chem 1990; 265:5938-41.
60. Marshall JF, Nesbitt SA, Helfrich MH, Horton MA, Polakova K, Hart IR. Integrin expression in human melanoma cell lines: heterogeneity of vitronectin receptor composition and function. Int J Cancer 1991; 49:924-31.
61. Pytela R, Pierschbacher MD, Ruoslahti E. A 125/115-kDa cell surface receptor specific for vitronectin interacts with the arginine-glycine-aspartic acid adhesion sequence derived from fibronectin. Proc Natl Acad Sci USA 1985; 82:5766-70.
62. Nakamura K, Yano H, Uchida H, Hashimoto S, Schaefer E, Sabe H. Tyrosine phosphorylation of paxillin alpha is involved in temporospatial regulation of paxillin-containing focal adhesion formation and F-actin organization in motile cells. J Biol Chem 2000; 275:27155-64.
63. Slack-Davis JK, Martin KH, Tilghman RW, Iwanicki M, Ung EJ, Autry C, et al. Cellular characterization of a novel focal adhesion kinase inhibitor. J Biol Chem 2007; 282:14845-52.
64. Thompson EW, Paik S, Brunner N, Sommers CL, Zugmaier G, Clarke R, et al. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 1992; 150:534-44.
65. Farina AR, Coppa A, Tiberio A, Tacconelli A, Turco A, Colletta G, et al. Transforming growth factor-beta1 enhances the invasiveness of human MDA-MB-231 breast cancer cells by upregulating urokinase activity. International Journal of Cancer 1998; 75:721-30.
66. Safina A, Vandette E, Bakin AV. ALK5 promotes tumor angiogenesis by upregulating matrix metalloproteinase-9 in tumor cells. Oncogene 2007; 26:2407-22.
67. Maeda M, Shintani Y, Wheelock MJ, Johnson KR. Src activation is not necessary for transforming growth factor (TGF)beta-mediated epithelial to mesenchymal transitions (EMT) in mammary epithelial cells. PP1 directly inhibits TGFbeta receptors I and II. J Biol Chem 2006; 281:59-68.
68. Erdogan M, Pozzi A, Bhowmick N, Moses HL, Zent R. Signaling pathways regulating TC21-induced tumorigenesis. J Biol Chem 2007; 282:27713-20.
69. Oft M, Heider KH, Beug H. TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol 1998; 8:1243-52. (Pubitemid 28540052)
70. Chan KT, Cortesio CL, Huttenlocher A. FAK alters invadopodia and focal adhesion composition and dynamics to regulate breast cancer invasion. J Cell Biol 2009; 185:357-70.
71. Sieg D, Hauck C, Schlaepfer D. Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. J Cell Sci 1999; 112:2677-91. (Pubitemid 29429791)
72. Michael KE, Dumbauld DW, Burns KL, Hanks SK, Garcia AJ. Focal adhesion kinase modulates cell adhesion strengthening via integrin activation. Mol Biol Cell 2009; 20:2508-19.
73. Parsons JT. Focal adhesion kinase: the first ten years. J Cell Sci 2003; 116:1409-16.
74. Ilic D, Kovacic B, Johkura K, Schlaepfer DD, Tomasevic N, Han Q, et al. FAK promotes organization of fibronectin matrix and fibrillar adhesions. J Cell Sci 2004; 117:177-87. (Pubitemid 38139231)
75. Puklin-Faucher E, Sheetz MP. The mechanical integrin cycle. J Cell Sci 2009; 122:179-86.
76. Zaidel-Bar R, Milo R, Kam Z, Geiger B. A paxillin tyrosine phosphorylation switch regulates the assembly and form of cell-matrix adhesions. J Cell Sci 2007; 120:137-48. (Pubitemid 46206656)
77. Zhang H, Li Z, Viklund E-K, Stromblad S. p21-activated kinase 4 interacts with integrin {alpha}v{beta}5 and regulates {alpha}v{beta}5-mediated cell migration. J Cell Biol 2002; 158:1287-97.
78. Ricono JM, Huang M, Barnes LA, Lau SK, Weis SM, Schlaepfer DD, et al. Specific Cross-talk between Epidermal Growth Factor Receptor and Integrin {alpha}v{beta}5 Promotes Carcinoma Cell Invasion and Metastasis. Cancer Res 2009; 69:1383-91.
79. Burgstaller G, Gimona M. Actin cytoskeleton remodelling via local inhibition of contractility at discrete microdomains. J Cell Sci 2004; 117:223-31. (Pubitemid 38128901)